Abstract
Estimates of mutation rates for various regions of the human mitochondrial genome (mtGenome) vary widely, depending on whether they are inferred using a phylogenetic approach or obtained directly from pedigrees. Traditionally, only the control region, or small portions of the coding region have been targeted for analysis due to the cost and effort required to produce whole mtGenome Sanger profiles. Here, we report one of the first pedigree derived mutation rates for the entire human mtGenome. The entire mtGenome from 225 individuals originating from Norfolk Island was analysed to estimate the pedigree derived mutation rate and compared against published mutation rates. These individuals were from 45 maternal lineages spanning 345 generational events. Mutation rates for various portions of the mtGenome were calculated. Nine mutations (including two transitions and seven cases of heteroplasmy) were observed, resulting in a rate of 0.058 mutations/site/million years (95% CI 0.031ā0.108). These mutation rates are approximately 16 times higher than estimates derived from phylogenetic analysis with heteroplasmy detected in 13 samples (nā=ā225, 5.8% individuals). Providing one of the first pedigree derived estimates for the entire mtGenome, this study provides a better understanding of human mtGenome evolution and has relevance to many research fields, including medicine, anthropology and forensics.
Similar content being viewed by others
Introduction
The mitochondrial genome (mtGenome), and the control region in particular, is the most analysed DNA sequence in human evolutionary studies. As a result, the rate of change in mitochondrial DNA (mtDNA) is relatively well understood. However, since the 1990s, evidence has emerged that mtDNA mutation rates vary widely and are dependent upon the estimation method used and the population studied (e.g. when comparing Swedes and Icelanders, respectively, in Cavelier et al.1 and Siguroardottir et al.2.
The rate at which mtDNA mutates is predominantly estimated using phylogenetic or pedigree methods. Phylogenetic analysis of mtDNA relies upon haplotype trees and phylogenetically derived divergence rates, while human pedigree-based mutation rates are estimated by comparison of parent/offspring pairs or using deep-rooted familial lineages at particular loci and counting the number of novel mutations per pair, and this value is then divided by the number of meioses3. Discrepancy exists between the estimates produced using these two methods, although recent progress in the analysis of ancient DNA has allowed for further improvement in the estimates4,5,6. Since the first noted7, the cause of this discrepancy has been extensively explored and several plausible causes have been suggested, namely: differences in the mutation rate at different locations within the mtGenome; sample size and selection; the effect of natural selection and genetic drift; the occurrence of somatic mutations; the unintended sequencing of nuclear mitochondrial pseudogenes (NUMTs); and the leakage of paternal mtDNA and recombination2,8,9,10,11,12,13. Thus, the choice of which estimate to use in population studies is determined by the specific purpose of the investigation. Phylogenetically based estimations may be more suited to investigations of deep history as this considers mutations that have reached a considerable frequency in the population. In contrast, pedigree-based estimations may be more suited to studies of recent history as newly acquired mutations that have not had time to become fixed within the population are considered12,14.
The human mtGenome is split into two sections: a large coding region that is responsible cellular energy production and for the gene production for transfer RNA (tRNA), ribosomal RNA (rRNA) translation; and a smaller control region15. The control region also contains the polymorphism-rich hypervariable regions (HVI and HVII), which are traditionally used for comparisons in missing persons cases, criminal cases and for historical military cases16. While the mitochondrial control region has been extensively studied, minimal literature explores the mutation rate for the entire mtGenome. Typically only the control region (or portions of) are examined due to the cost and effort required to produce whole mtGenome Sanger profiles and the perceived stability of the remainder of the genome. The advent of Next Generation Sequencing (NGS) technologies has provided impetus and the potential to expand the current body of knowledge surrounding the prediction of mutation rates.
In an effort to estimate the mutation rate of the entire human mtGenome using a non-phylogenetic approach, we utilised 225 members of the most recent four generations of the Norfolk Island (NI) core pedigree17,18,19,20,21 and compared entire mtGenome sequences of maternal relatives from 45 maternal lineages. NI is a small, remote island in the Pacific with a unique admixture of paternal European ancestry in combination with Polynesian maternal origins22. The population has a well-documented history and genealogy. Accurate and detailed historical accounts have been used by genealogists to create and maintain a well-documented, large multigenerational NI pedigree which consists of 5742 individuals spanning 11 generations, and 200Ā years to the original founders23. Due to the many inbreeding loops found in the populationās early generations, and the size and complexity, the NI pedigree was reconstructed to include all core individuals relating back to the original founders (nā=ā1388)21.
This study defines one of the first pedigree derived mutation rates encompassing the entire human mtGenome. As with SigurĆ°ardĆ³ttir et al.2, we define mutation rate as the rate at which the mtDNA of an individual changes, rather than the rate of sequence change at the level of an individual mitochondria. The expansion of the current paradigms and evidence of mutation rates allows researchers to more fully understand the processes that have shaped the evolution of the human mtGenome. Our findings have application and implications for various research fields including clinical genetics, human evolution and forensic identity testing.
Results
Whole mtGenome sequencing to identify mtDNA variants in the Norfolk Island pedigree
The whole mtGenome was sequenced for 225 individuals representing 45 independent mtDNA lineages from the core pedigree of the NI population isolate on an Ion Torrent NGS platform (Fig.Ā 1). Sequence quality (Phred) scores remained consistent atā>ā25 for all samples at the median read length (140Ā bp), with data reaching a median depth of approximately 370X for all 225 samples. Sequencing reads were aligned in relation to the rCRS and variants annotated using Mitomaster, with called variants subsequently validated by Sanger Sequencing.
In this study, NGS analysis of homopolymer stretches (such as poly C regions) were a challenge for the Ion Torrent platform resulting in sequencing slippage in regions containing long homopolymer stretches. This is due to the degree of change in voltage loss resolution (above 6ā8Ā bp) inherent to the platform. As a result, these regions have poor mapping quality and can lead to false-positive and false-negative calls and typically require assessment using alternative methods. The identification and calling INDELS also presented a bioinformatic challenge in the samples due to sequencing error bias and required a higher level of manual assessment. Issues in sequencing data in homopolymeric regions are not unique to NGS. Sanger sequencing is also susceptible to such errors24, with all sequencing platforms prone to sequencing errors corresponding to the chemistry and platforms used25.
In the rCRS, position T16189 is flanked by cytosine residues between positions 16183 and 16194. In the samples examined in this study, this sequence stretch was consistently and reproducibly represented in NGS and Sanger data analysis when no length or point variation was present. However, in 134 samples (nā=ā225, 59.6%), a combination of the T16189C transition and a deletion at position 16189 resulted in low coverage values and unreliable Sanger data for this region. Consequently, it became difficult to determine the number of cytosine residues present. In accordance with Interpretation Guidelines for mtDNA Sequencing outlined by the Laboratory Division of the FBI26, no attempt was made to count the number of residues for interpretation purposes and all comparisons assumed the same number were present. Similar results were obtained for the HVII C-track between position 302 to 310 and 310 to 316. Difficulties were also observed when an insertion of one or more Cs (resulting in a stretch ofāā„ā8 C residues) were present. Mutations in these regions were omitted during the comparison of maternally related individuals, and hence were not included in the mutation rate calculations performed in this study.
Calculation of mutation rates across the mtGenome
When the individual pedigrees were examined, the number of meioses and mutations were observed (Table 1). Homoplasmic mutations were found at two different sites in one individual each. Heteroplasmy was confirmed at 7 positions across 13 individuals (nā=ā225, 5.78% individuals). Analysis of the individuals belonging to 45 families from NI revealed 13.3% of the families contained at least one individual with mtDNA heteroplasmy as a result of mutation across the entire mtGenome. The frequency of point heteroplasmy in the NI samples did not show significant differences in relation to gender (Chi-squared test: X2ā=ā0.472, dfā=ā1, Pā=ā0.492), nor was it found to be associated with a specific mtDNA haplogroup (Fisher exact test: Pā=ā0.080).
Further analysis of the 345 mtDNA transmissions identified 9 mutations (2 transitions and 7 cases of heteroplasmy) across the entire mtGenome, suggesting that 1.57āĆā10ā6 mutations occur (at a detectable level) in the mtGenome in each generation. Assuming a generation time of 26.9Ā years, the mutation rate for the entire mtGenome would be 0.058 mutations/site/Myr when including heteroplasmy (95% CI 0.031ā0.108), and 0.013 mutations/site/Myr when excluding heteroplasmy (95% CI 0.003ā0.047) (Table 2). In order to make an estimate of separate mutation rates for the HVI and HVII regions, HVI was delimited by positions 16024ā16383 (360Ā bp) and HVII delimited by positions 57ā371 (315Ā bp) in accordance withĀ Sigurgardottir et al.2.
Discussion
Mutation rate
In the analysis of 345 genetic transmissions, 9 mutations (2 transitions and 7 cases of heteroplasmy) were detected across the entire mtGenome, suggesting the mutation rate for the entire mtGenome to be 0.058 mutations/site/Myr (95% CI 0.031ā0.108). Table 3 compares the derived mutation rate for each region calculated using the NI samples with previous studies using closed populations. NI sample derived mutation rates are shown in bold.Ā For consistency, mutation rates for each study were converted to mutations/site/Myr with a defined generation time of 25Ā years. Only rates that could be accurately standardised were included in the table. As such, a number of published rates were excluded, for example those by28,29,30,31,32,33,34,35.
Note that although rates are grouped based on region (such as control region, coding region), the sequence range varies from study to study. Furthermore, inclusion requirements varied for each study impacting the rate calculated (for example, only substitutions for which there was evidence of a germinal origin were considered in Santos et al.9, or all substitutions detected were considered in Madrigal et al.36). As expected, the mutation rate for the coding region was found to be smaller than that reported for the control region, and as with other studies, the estimation reported here is much higher than those obtained by phylogenetic methods (Table 3).
In the NI samples, with the exception of the coding region, the mutation rate calculated for various regions of the mtGenome were found to be relatively high when compared to previous published studies. This may be attributed to differences in the population examined, study design or analysis. In this study, the rates calculated for the NI population included all mutations (heteroplasmy, germline, somatic). In contrast, for the HVI region, Santos et al.9 reported a mutation rate of 0.074 mutations/site/Myr (16ātimesālower than the rate for NI: 1.2 mutations/site/Myrāboth using a generation time of 25Ā years), however their rate only included substitutions (including heteroplasmy) with a germinal origin present in women fixed at the individual level. While inclusion criteria alone does not fully explain the variations identified via pedigree-derived mutation rates, it likely contributes to the observed difference.
Interestingly, the mutation rate for the coding region was one of the smallest rates reported, despite our study being the only one to examine the entire region (bases 576ā16024). This variation could be due to population differences. NI is a small, isolated population, and therefore the evolution of extremely high mutation rates is unlikely to occur unless organisms are under special circumstances37, with beneficial mutations rarely compensating for deleterious mutations.
In addition, heteroplasmic variants were not included in all studies assessing the mutation rate of mtDNA (for example1). It is reasonable to suggest that heteroplasmy may resolve in favour of a ānewā base, and therefore, exclusion of heteroplasmic variants may underestimate the true mutation rate. However, the inclusion of heteroplasmic mutations introduces the limitation that only those that have reached a level of 20% of the mtDNA population are deemed detected. This raises the question of whether the discrepancy between phylogenetic and pedigree derived rates could be answered by simply excluding heteroplasmic variants, on the presumption that they will not become homoplasmic and/or will not be transmitted at the level of the population. Heteroplasmic mutations that reached 20%, the minimum threshold required to be included in the pedigree derived mutation rate reported here, should have a higher probability of becoming homoplasmic than those reaching only 1ā2%.
Heteroplasmy
Several previous studies have demonstrated Sanger sequencing to be valid for quantification of heteroplasmy greater than 10% and that NGS could detect and quantify heteroplasmy as low as 1%45. In this study, to ensure robustness of the data and subsequent analysis, a threshold of 20% or greater was used. Previous studies have also performed independent DNA extraction, PCR amplification and sequencing to authenticate heteroplasmy results and exclude any contamination9,46,47. Here, heteroplasmy was confirmed via Sanger sequencing.
Point heteroplasmy was confirmed at 7 positions across 13 samples (nā=ā225, 5.8% individuals), a rate found to be lower than other studies that have previously sequenced the entire mtGenome. Ramos et al.46 observed point heteroplasmy in 12.8% of samples (13 of 101 individuals), while Santos et al.9 observed point heteroplasmy in 12.1% of samples (28 of 232 individuals). Neither of these studies used NGS and both methodologies relied upon the same method to quantify levels of heteroplasmy. Specifically, these studies measured the height of the two peaks directly from the sequencing electropherogram and calculated the proportion between the heights of each peak with respect to the sum of the height of the two peaks. For comparison purposes, the obtained numerical proportions were then averaged. Another method previously used included cloning PCR products encompassing the D-loop region and subsequent sequencing of the 26ā66 clones to determine the number containing each mtDNA variant9,46. The increased percentage of heteroplasmy observed in those studies when compared to ours could be due to the lower minor variant threshold used. The threshold used in Ramos et al.46 was 10%, and although no threshold was stated in Santos et al.9, that study included cases of heteroplasmy where the minor variant was as low as 2.5%. In addition to those outlined in Table 1, heteroplasmic mixtures below the 20% threshold were observed in three additional individuals, with MAFs of 12, 15 and 15% for A16280R, T9012Y and C16320, respectively. As these were below the 20% threshold, they were not considered in any further analysis. Further heteroplasmic variants may be evident at other positions across the mtGenome if our threshold was reduced to one comparable with Ramos et al.46 or Santos et al.9. In our study, 6.7% (nā=ā45) of the NI pedigrees examined, at least one individual within the lineage presented mtDNA heteroplasmy produced by mutations across the coding region. This value is consistent with the percentage reported by Santos et al.43 (6.5% of families). Interestingly, no individuals from the NI pedigrees examined in this study showed heteroplasmy at the positions examined by Santos et al.43.
Length heteroplasmy is typically observed in every individual where a transition at position T16189 results in a homopolymer of nine or more cytosine residues, with no length heteroplasmy observed when seven or fewer cytosine residues are present48,49,50,51. In the NI samples, consistent and reliable Sanger sequencing was not achieved for individuals that exhibited the T16189 transition and therefore, length heteroplasmy could not be confirmed. Hence, to ensure consistent reporting, the decision was made to disregard variants in positions 16180ā16183 for all samples. The poly-C tracks of both the HVI and HVII regions are known to have high insertion/deletion rates, resulting in length heteroplasmy52. For example, Santos et al.9 reported length heteroplasmy produced by the insertion of cytosine residues in the poly-C tract of HVRI and HVRII respectively in 22.92% and 54.16% of the families studied. It is accepted that the general mechanism for generating length heteroplasmy in these regions is replication slippage53. These regions were also excluded during the analysis of the NI individuals and no other length heteroplasmy in any region was observed in the NI samples.
Conclusion
The mtDNA control region is commonly used to assess human evolution and population movements. Many of these studies rely on phylogenetic analysis of mtDNA control region haplotype trees and phylogenetically derived rates of divergence. Estimates of the mutation rate with a non-phylogenetic approach (namely pedigree analysis) are reported to be approximately ten-fold higher than phylogenetically derived rates. Using a pedigree approach, 9 mutations (2 transitions and 7 cases of heteroplasmy) were identified across the entire human mtGenome, resulting in a mutation rate (obtained by employing the same definition of mutation used by other authors) of 0.058 mutations/site/Myr (95% CI 0.031ā0.108). The mutation rate produced from this study is one of the first to use extended pedigree analysis of the entire human mtGenome in combination with NGS. If mutations arise randomly in the mtGenome, these results suggest that newly arising mutations in the human mitochondrial coding region are eliminated before they reach a detectable frequency. Defining this mechanism may provide further insight into the interpretation of human mtGenome data across numerous fields of study.
Materials and methods
Ethics
Ethical clearance for the Norfolk Island mitochondrial DNA analysis portion of this study was provided originally by the Griffith University Human Research Ethics Committee (Approval MSC/04/09/HREC). Ethical clearance was transferred to and is now provided by the Queensland University of Technology Human Research Ethics Committee (Approval Number: 1400000749). No other ethical clearance was required. All analyses were performed in accordance with relevant guidelines and regulations, and all Norfolk participants provided informed consent for research involvement.
Sample selection
This research used individuals from the NI Health Study and the associated NI core pedigree for research investigations at Queensland University of Technology. The NI Health Study has been well described in previous research17,18,19,20,21. The NI core pedigree contains individuals that are most closely related to the original founders. For illustration, the NI core pedigree is shown in Fig.Ā 1. Using the NI core pedigree, maternal pedigrees were generated by establishing a list of founding mothers and tracing their maternal lines. Resultant pedigrees were generated using the Pedigree v1.454, Kinship2 v1.8.555 and Tidyverse v1.3.156 packages. All pedigree analysis was conducted in RStudio v1.457. The code utilised for the generation of pedigrees shown in Figs.Ā 1 and 2 is available in the GitHub repository http://sirselim.github.io/presentations/mt_tracing.html. In total, 45 resultant pedigrees (families) were chosen (Fig.Ā 2). From these families, 225 individuals (including 125 females and 100 males) were chosen for sequencing, corresponding to 345 mtDNA transmissions. All individuals chosen were from the last four generations of the NI core pedigree and relate back to the original founders.
Whole mtGenome sequencing
The entire human mtGenome was amplified using long-range PCR with two overlapping primer sets (fragment 1: mt.569ā9819, F: 5ā²-AACCAAACCCCAAAGACACC-3ā² and R:Ā 5ā²-GCCAATAATGACGTGAAGTCC-3ā²; and fragment 2: mt.9611ā626, F:Ā 5ā²-TCCCACTCCTAAACACATCC-3ā² and R:Ā 5ā²-TTTATGGGGTGATGTGAGCC-3ā²). Library preparation and sequencing was performed using an Ion Torrent high throughout sequencing protocol established in-house58.
Data analysis
Data analysis was performed using the bioinformatics pipeline outlined in Harvey et al.58. Sequences were obtained for the entire mtGenome and were aligned in relation to the revised Cambridge Reference Sequence (rCRS)59 using an online tool Mitomaster to annotate variants and call haplotype information for each sample60.
Length variants that are known hotspots for insertion and deletions (indels) were ignored, including positions 309, 455, 463, 573, 960, 5899, 8276, 8285 and 16193 relative to the rCRS61. Variants in positions 16180ā16183 were also ignored as reliable sequence data could not be obtained (see āResultsā and āDiscussionā sections).
In cases of lengthy heteroplasmy, a single dominant variant was identified. In cases of point heteroplasmy, the position was deemed heteroplasmic if the following requirements were achieved:
-
1.
For NGS data, the minor allele frequency was greater than 20% (of total coverage). This threshold was chosen to reliably differentiate between signal and noise and reduce false positives.
-
2.
When sequenced using Sanger sequencing, the minor allele was readily visible (a distinct peak of normal morphology was evident and white space beneath the peak could be observed without changing the chromatogram view to examine the signal closer to the baseline)48.
-
3.
The minor allele was evident in two different high-quality Sanger sequences (for example, when using both forward and reverse primers).
All mutations were confirmed using Sanger sequencing. Amplification was performed in a 25Ā Ī¼L total reaction volume using 1.6Ā Ī¼L magnesium chloride, 5Ā Ī¼L 5X GoTaq Colourless Flexi Reaction Buffer, 0.5Ā Ī¼L of 10Ā mM dNTPs, 9.4Ā Ī¼L deionised water, 2Ā Ī¼L GoTaq Hot Start Polymerase, 2Ā Ī¼L of each 10Ā Ī¼M amplification primer and 50Ā ng DNA extract. Thermal cycling conditions were 95Ā Ā°C for 30Ā s; 30 cycles of 95Ā Ā°C for 30Ā s, 57Ā Ā°C for 40Ā s, 72Ā Ā°C for 30Ā s; and a 68Ā Ā°C hold for 3Ā min. Purification of amplified products prior to sequencing was performed using ExoSAP-IT PCR Product Clean-up Reagent, using 5Ā Ī¼L PCR product, 4Ā Ī¼L deionised water, and 1Ā Ī¼L ExoSAP-IT. Thermal cycling conditions were as per the manufacturerās instructions. Sequencing was performed via the BigDye Terminator v3.1 Cycle Sequencing Kit. Reactions consisted of 9.64Ā Ī¼L deionized water; 4Ā Ī¼L BigDye Terminator v3.1 Sequencing Buffer; 0.5Ā Ī¼L BigDye Terminator v3.1 Ready Reaction Mix; 3.2Ā Ī¼L sequencing primer at 10Ā Ī¼M; and 2.66Ā Ī¼L PCR product for a total reaction volume of 20Ā Ī¼L. Thermal cycling conditions used were: 96Ā Ā°C hold for 1Ā min; 30 cycles of 96Ā Ā°C for 10Ā s, 50Ā Ā°C for 5Ā s, and 60Ā Ā°C for 4Ā min; followed by 1 cycle of 4Ā Ā°C for 5Ā min and 10Ā Ā°C for 5Ā min. Sequence product purification was performed via ethanol precipitation. Sequence detection was performed by capillary electrophoresis on a 3500 Genetic Analyser using a 50Ā cm array, the FastSeq instrument protocol with default instrument settings. Amplification and sequencing primers are outlined in Supplementary Table S1.
The mutation rate was derived from the number of detected mutations per number of āmeiosesā or transmission events, which is the number of cumulative generations tracing back to the maternal ancestor. Genealogical records for a sample of 222 individuals from Norfolk Island suggest that the average maternal intergenerational time is 26.9Ā years. The mutation rate is expressed as mutations per base pair (site) per million years (mutations/site/Myr), where the generational time was assumed to be 26.9Ā years. Different values of the mutation rate were estimated according to different assumptions: (1) all mutations that were detected (including heteroplasmy) were considered for the mutation rate calculation, and (2) all mutations that were detected (excluding heteroplasmy) were considered for the mutation rate calculation.
Confidence intervals (CIs: 95%) were calculated using Epitools, an online tool provided by AusVet Animal Health Services62. The program outputs intervals using five alternative calculation methods as described in Brown et al.63. The Wilson and Clopper Pearson methods were reported.
Data availability
The data that support the findings of this study have restricted access due to ethical requirements and agreements with the Norfolk Island community, and so are not publicly available. Aggregate data may, however, be made available from the authors upon request. The Norfolk genetics steering committee will assess data access requests via our GRC computational genetics group (interested researchers should contact grccomputationalgenomics@gmail.com).
Code availability
The code utilised for this study is available in the GitHub repository https://github.com/GRC-CompGen/mitochondrial_seq_pipeline and http://sirselim.github.io/presentations/mt_tracing.html.
References
Cavelier, L., Jazin, E., Jalonen, P. & Gyllensten, U. MtDNA substitution rate and segregation of heteroplasmy in coding and noncoding regions. Hum. Genet. 107, 45ā50 (2000).
SigurÄardĆ³ttir, S., Helgason, A., Gulcher, J. R., Stefansson, K. & Donnelly, P. The mutation rate in the human mtDNA control region. Am. J. Hum. Genet. 66, 1599ā1609 (2000).
Henn, B. M., Gignoux, C. R., Feldman, M. & Mountain, J. L. Characterizing the time dependency of human mitochondrial DNA mutation rate estimates. Mol. Biol. Evol. 26, 217ā230 (2009).
Cabrera, V. M. Human molecular evolutionary rate, time dependency and transient polymorphism effects viewed through ancient and modern mitochondrial DNA genomes. Sci. Rep. 11, 5036 (2021).
Leonardi, M. et al. Evolutionary patterns and processes: Lessons from ancient DNA. Syst. Biol. 66, e1āe29 (2017).
Tong, K. J., DuchĆŖne, D. A., DuchĆŖne, S., Geoghegan, J. L. & Ho, S. Y. W. A comparison of methods for estimating substitution rates from ancient DNA sequence data. BMC Evol. Biol. 18, 70 (2018).
Howell, N., Kubacka, I. & Mackey, D. A. How rapidly does the human mitochondrial genome evolve?. Am. J. Hum. Genet. 59, 501ā509 (1996).
Ho, S. et al. Time-dependent rates of molecular evolution. Mol. Ecol. 20, 3087ā3101 (2011).
Santos, C. et al. Understanding differences between phylogenetic and pedigree-derived mtDNA mutation rate: A model using families from the Azores Islands (Portugal). Mol. Biol. Evol. 22, 1490ā1505 (2005).
Howell, N. et al. The pedigree rate of sequence divergence in the human mitochondrial genome: There is a difference between phylogenetic and pedigree rates. Am. J. Hum. Genet. 72, 659ā670 (2003).
Parsons, T. et al. A high observed substitution rate in the human mitochondrial DNA control region. Nat. Genet. 15, 363ā368 (1997).
Macaulay, V. et al. mtDNA mutation ratesāNo need to panic. Am. J. Hum. Genet. 61, 983ā990 (1997).
Ho, S. Y. W., Phillips, M. J., Cooper, A. & Drummond, A. J. Time dependency of molecular rate estimates and systematic overestimation of recent divergence times. Mol. Biol. Evol. 22, 1561ā1568 (2005).
PƤƤbo, S. Mutational hot spots in the mitochondrial microcosm. Am. J. Hum. Genet. 59, 493ā496 (1996).
Kareem, M. A., Abdulzahra, A. I., Hameed, I. H. & Jebor, M. A. A new polymorphic positions discovered in mitochondrial DNA hypervariable region HVIII from central and north-central of Iraq. Mitochondrial DNA Part A 27, 3250ā3254 (2016).
Melton, T., Holland, C. & Holland, M. Forensic mitochondrial DNA analysis: Current practice and future potential. Forensic Sci. Rev. 24, 101ā122 (2012).
Bellis, C. et al. Phenotypical characterisation of the isolated Norfolk Island population focusing on epidemiological indicators of cardiovascular disease. Hum. Hered. 60, 211ā219 (2005).
Bellis, C. et al. Linkage disequilibrium analysis in the genetically isolated Norfolk Island population. Heredity 100, 366ā373 (2008).
Cox, H. C. et al. Principal component and linkage analysis of cardiovascular risk traits in the Norfolk Isolate. Hum. Hered. 68, 55ā64 (2009).
Benton, M. C. et al. Mapping eQTLs in the Norfolk Island genetic isolate identifies candidate genes for CVD risk traits. Am. J. Hum. Genet. 93, 1087ā1099 (2013).
Benton, M. et al. āMutiny on the Bountyā: The genetic history of Norfolk Island reveals extreme gender-biased admixture. Investig. Genet. 6, 1 (2015).
Mcevoy, B. P. et al. European and Polynesian admixture in the Norfolk Island population. Hered. Cardiff 105, 229ā234 (2010).
Macgregor, S. et al. Legacy of mutiny on the Bounty: Founder effect and admixture on Norfolk Island. Eur. J. Hum. Genet. EJHG 18, 67ā72 (2010).
Yohe, S. & Thyagarajan, B. Review of clinical next-generation sequencing. Arch. Pathol. Lab. Med. 141, 1544ā1557 (2017).
Ratan, A. et al. Comparison of sequencing platforms for single nucleotide variant calls in a human sample. PLOS ONE 8, e55089 (2013).
Budowle, B., DiZinno, J. A. & Wilson, M. R. Interpretation guidelines for mitochondrial DNA sequencing. In 10th International Symposium on Human Identification (10th International Symposium on Human Identification, 1999).
Nomenclature Committee of the International Union of Biochemistry. Nomenclature for incompletely specified bases in nucleic acid sequences. Recommendations 1984. Biochem. J. 229, 281ā286 (1985).
Mishmar, D. et al. Natural selection shaped regional mtDNA variation in humans. Proc. Natl. Acad. Sci. USA. 100, 171ā176 (2003).
Cann, R. L., Stoneking, M. & Wilson, A. Mitochondrial DNA and human evolution. Nature 325, 31ā36 (1987).
Torroni, A. et al. mtDNA and Y-chromosome polymorphisms in four Native American populations from southern Mexico. Am. J. Hum. Genet. 54, 303 (1994).
Soodyall, H. et al. The founding mitochondrial DNA lineages of Tristan da Cunha Islanders. Am. J. Phys. Anthropol. 104, 157ā166 (1997).
Pesole, G., SbisĆ”, E., Preparata, G. & Saccone, C. The evolution of the mitochondrial D-loop region and the origin of modern man. Mol. Biol. Evol. 9, 587ā598 (1992).
Heyer, E. et al. Phylogenetic and familial estimates of mitochondrial substitution rates: Study of control region mutations in deep-rooting pedigrees. Am. J. Hum. Genet. 69, 1113ā1126 (2001).
Vigilant, L., Stoneking, M., Harpending, H., Hawkes, K. & Wilson, A. C. African populations and the evolution of human mitochondrial DNA. Science 253, 1503ā1507 (1991).
Llamas, B. et al. Ancient mitochondrial DNA provides high-resolution time scale of the peopling of the Americas. Sci. Adv. 2, e1501385 (2016).
Madrigal, L. et al. High mitochondrial mutation rates estimated from deep-rooting Costa Rican pedigrees. Am. J. Phys. Anthropol. 148, 327ā333 (2012).
Sniegowski, P. D., Gerrish, P. J., Johnson, T. & Shaver, A. The evolution of mutation rates: separating causes from consequences. BioEssays 22, 1057ā1066 (2000).
Horai, S., Hayasaka, K., Kondo, R., Tsugane, K. & Takahata, N. Recent African origin of modern humans revealed by complete sequences of hominoid mitochondrial DNAs. Proc. Natl. Acad. Sci. 92, 532ā536 (1995).
Rieux, A. et al. Improved calibration of the human mitochondrial clock using ancient genomes. Mol. Biol. Evol. 31, 2780ā2792 (2014).
Rebolledo-Jaramillo, B. et al. Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA. Proc. Natl. Acad. Sci. 111, 15474ā15479 (2014).
Fu, Q. et al. A revised timescale for human evolution based on ancient mitochondrial genomes. Curr. Biol. CB 23, 553ā559 (2013).
Ingman, M., Kaessmann, H., PƤƤbo, S. & Gyllensten, U. Mitochondrial genome variation and the origin of modern humans. Nature 408, 708ā713 (2000).
Santos, C. et al. Mutation patterns of mtDNA: Empirical inferences for the coding region. BMC Evol. Biol. 8, 167 (2008).
Brotherton, P. et al. Neolithic mitochondrial haplogroup H genomes and the genetic origins of Europeans. Nat. Commun. 4, 1764 (2013).
Kloss-BrandstƤtter, A. et al. Validation of next-generation sequencing of entire mitochondrial genomes and the diversity of mitochondrial DNA mutations in oral squamous cell carcinoma. PLoS ONE 10, e0135643 (2015).
Ramos, A. et al. Frequency and pattern of heteroplasmy in the complete human mitochondrial genome. PLOS ONE 8, e74636 (2013).
Santos, C. et al. Frequency and pattern of heteroplasmy in the control region of human mitochondrial DNA. J. Mol. Evol. 67, 191ā200 (2008).
Just, R. et al. Full mtGenome reference data: Development and characterization of 588 forensic-quality haplotypes representing three US populations. Forensic Sci. Int. Genet. 14, 141ā155 (2015).
Melton, T. Mitochondrial DNA Heteroplasmy. Forensic Sci. Rev. 16, 1ā20 (2004).
Lee, H. Y., Chung, U., Yoo, J.-E., Park, M. J. & Shin, K.-J. Quantitative and qualitative profiling of mitochondrial DNA length heteroplasmy. Electrophoresis 25, 28ā34 (2004).
Irwin, J. et al. Investigation of heteroplasmy in the human mitochondrial DNA control region: A synthesis of observations from more than 5000 global population samples. J. Mol. Evol. 68, 516ā527 (2009).
Hauswirth, W. W. & Clayton, D. A. Length heterogeneity of a conserved displacement-loop sequence in human mitochondrial DNA. Nucleic Acids Res. 13, 8093ā8104 (1985).
Hauswirth, W., Van De Walle, M., Olivo, P. & Laipis, P. Heterogeneous mitochondrial DNA D-loop sequences in bovine tissue. Cell 37, 1001ā1007 (1984).
Coster, A. pedigree. (2013).
Therneau, T. M., Daniel, S., Sinnwell, J. & Atkinson, E. kinship2. (2015).
Wickham, H. & RStudio. tidyverse. (2017).
RStudio. (2017).
Harvey, N. R. et al. Ion torrent high throughput mitochondrial genome sequencing (HTMGS). PLOS ONE 14, e0224847 (2019).
Andrews, R. M. et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 23, 147 (1999).
MITOMAP. MITOMAP A human mitochondrial genome database. http://www.mitomap.org/MITOMAP (2017).
Parson, W. EMPOP mtDNA Database Directions for Use (2019).
AusVet Animal Health Services. Epi ToolsāCalculate confidence limits for a sample proportion. http://epitools.ausvet.com.au/content.php?page=CIProportion (2016).
Brown, L. D., Cai, T. T. & DasGupta, A. Interval estimation for a binomial proportion. Stat. Sci. 16, 101ā133 (2001).
Acknowledgements
We wish to acknowledge the Norfolk Island individuals who have generously donated their DNA samples and time to participate in this research study and for the ongoing community support which aids our research.Ā The Norfolk Island mitochondrial analysis was supported by NHMRC grantsĀ 376608, 536518 and 1058806. This research was also supported by infrastructure purchased with Australian Government EIF Super Science Funds as part of the Therapeutic Innovation AustraliaāQueensland Node project (L.R.G.). In addition, Jasmine Connell was the recipient of an Institute of Health and Biomedical Innovation (IHBI) Queensland University of Technology (QUT) postgraduate student scholarship and Miles Benton was supported by a Corbett Postgraduate Research Grant.
Funding
Institute of Health and Biomedical InnovationĀ Postgraduate StudentĀ Scholarship, J.R.C.;Ā Corbett Postgraduate Research Grant,Ā M.C.B.;Ā National Health and Medical Research CouncilĀ grantsĀ 376608, 536518Ā andĀ 1058806, L.R.G.;Ā Australian Government EIF Super Science Funds as part ofĀ Therapeutic Innovation AustraliaāQueensland Node project,Ā L.R.G.
Author information
Authors and Affiliations
Contributions
J.R.C.: conceptualization, formal analysis, investigation, methodology, validation, writingāoriginal draft, review and editing; M.C.B.: methodology, writingāreview and editing; R.A.L.: methodology, analysis review, writingāreview and editing; H.G.S.: sample preparation, quality control, writingāreview and editing; J.C.: conceptualization, supervision, writingāreview and editing; L.M.H.: conceptualization, project administration, supervision, writingāreview and editing; K.M.W.: conceptualization, project administration, resources, supervision, writingāreview and editing; L.R.G.: conceptualization, project administration, resources, supervision, writingāreview and editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Connell, J.R., Benton, M.C., Lea, R.A. et al. Pedigree derived mutation rate across the entire mitochondrial genome of the Norfolk Island population. Sci Rep 12, 6827 (2022). https://doi.org/10.1038/s41598-022-10530-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-10530-3
This article is cited by
-
New Canary Islands Roman mediated settlement hypothesis deduced from coalescence ages of curated maternal indigenous lineages
Scientific Reports (2024)
-
The maternal ancestry of the Kavaratti islanders and the last glacial maximum aftermath
Molecular Genetics and Genomics (2023)
-
Mitochondrial DNA Analysis in Population Isolates: Challenges and Implications for Human Identification
Current Molecular Biology Reports (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.